Sandra Horning
Hematology & Oncology · Stanford, CANPI 1578607669
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,328,709 of the $2,486,406 with a category attached, or 93.7%. Gilead accounts for 82.0% of it on its own, with 2 other manufacturers making up the rest. Among hematology & oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 233 payments — averaging $10,671 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2M
- Modernatx, Inc.$447K
- Genentech USA, Inc.$135
What the payments were for
- Consulting fees$2,328,70994%
- Speaking & faculty fees$119,9495%
- Travel & lodging$31,2331%
- Food & beverage$6,5160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 191 | $2,038,904 |
| Modernatx, Inc. | 41 | $447,368 |
| Genentech USA, Inc. | 1 | $135 |
How this compares
$2,486,406 in reported general payments places this provider in the 95th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Stanford
- Dennis SlamonLos Angeles$3.1M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
- Richard FinnSanta Monica$784K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.